GKIM
CVS icon

GW&K Investment Management’s CVS Health CVS Stock Holding History

GW&K Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95K Sell
916
-20
-2% -$1.78K ﹤0.01% 487
2026
Q1 		$67K Sell
936
-43
-4% -$3.31K ﹤0.01% 513
2025
Q4 		$78K Buy
979
+62
+7% +$4.89K ﹤0.01% 479
2025
Q3 		$69K Sell
917
-41
-4% -$2.81K ﹤0.01% 487
2025
Q2 		$66K Buy
958
+321
+50% +$21K ﹤0.01% 472
2025
Q1 		$43K Buy
637
+180
+39% +$10.8K ﹤0.01% 513
2024
Q4 		$21K Sell
457
-205
-31% -$11.5K ﹤0.01% 608
2024
Q3 		$42K Buy
662
+187
+39% +$10.9K ﹤0.01% 482
2024
Q2 		$28K Sell
475
-63
-12% -$3.94K ﹤0.01% 507
2024
Q1 		$43K Buy
538
+17
+3% +$1.3K ﹤0.01% 447
2023
Q4 		$41K Buy
521
+4
+0.8% +$285 ﹤0.01% 426
2023
Q3 		$36K Buy
517
+106
+26% +$7.51K ﹤0.01% 419
2023
Q2 		$28K Buy
+411
New +$29.2K ﹤0.01% 435
2022
Q3 		– Sell
-611
Closed -$57K – 502
2022
Q2 		$57K Sell
611
-195
-24% -$19K ﹤0.01% 377
2022
Q1 		$82K Buy
+806
New +$84.7K ﹤0.01% 358

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

GW&K Investment Management's CVS Position: Q2 2026 in Review

GW&K Investment Management reduced its CVS Health (CVS) stake by 2.1% in Q2 2026, selling an estimated $1.78K and leaving 916 shares worth $95K. The position accounts for ﹤0.01% of the portfolio, ranked #487.

GW&K Investment Management first reported a position in CVS in Q1 2022 and has held it in 15 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • GW&K Investment Management held 916 shares of CVS Health worth $95K as of Q2 2026.
  • GW&K Investment Management sold 20 CVS Health shares in Q2 2026, an estimated $1.78K.
  • CVS Health made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #487 holding.
  • GW&K Investment Management first reported a position in CVS Health in Q1 2022 and has held it in 15 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.